影响子痫前期或子痫使用硫酸镁的因素:定性证据综合
该定性证据综合检索1995年1月至2021年6月多个数据库,纳入22项主要来自中低收入国家的研究,从医护人员、管理者和政策制定者视角分析影响硫酸镁用于子痫前期/子痫的因素。研究采用主题综合法和COM-B行为改变理论,识别出提供者能力与信心、卫生系统可及性及知识转化等促进与障碍因素,可为指南制定和临床实施提供依据。
要点
- 医护人员给药能力与信心影响硫酸镁使用
- 卫生系统确保硫酸镁在用点可及的能力是关键
- 知识转化即研究和推荐的传播影响临床实践
核心结论
- 影响硫酸镁使用的因素涉及提供者能力与信心、卫生系统可及性及知识转化,可指导政策与指南制定并改善临床实施。
研究设计与样本
- 定性证据综合,检索MEDLINE、EMBASE、Emcare、CINAHL、Global Health和Global Index Medicus及灰色文献,纳入1995年1月至2021年6月发表的22项原始定性和混合方法研究。
主要发现
- 纳入研究主要来自中低收入国家,关键主题包括提供者给药的能力与信心、卫生系统确保硫酸镁在用点可及的能力以及知识转化。
- 在COM-B各领域内映射了身体与心理能力、身体与社会机会的促进和障碍因素及其对动机的交互影响。
临床怎么用
- 可利用这些发现制定政策和指南,改善硫酸镁在临床护理中的实施,确保这一挽救生命的治疗广泛可及并合理使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO4 ) is recommended for prevention and treatment of pre-eclampsia/eclampsia. However, MgSO4 remains underused, particularly in low- and middle-income countries (LMICs). OBJECTIVE: This qualitative evidence synthesis explores perceptions and experiences of healthcare providers, administrators and policy-makers regarding factors affecting use of MgSO4 to prevent or treat pre-eclampsia/eclampsia. SEARCH STRATEGY: We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021. SELECTION CRITERIA: Primary qualitative and mixed-methods studies on factors affecting use of MgSO4 in healthcare settings, from the perspectives of healthcare providers, administrators and policy-makers, were eligible for inclusion. DATA COLLECTION AND ANALYSIS: We applied a thematic synthesis approach to analysis, using COM-B behaviour change theory to map factors affecting appropriate use of MgSO4 . MAIN RESULTS: We included 22 studies, predominantly from LMICs. Key themes included provider competence and confidence administering MgSO4 (attitudes and beliefs, complexities of administering, knowledge and experience), capability of health systems to ensure MgSO4 availability at point of use (availability, resourcing and pathways to care) and knowledge translation (dissemination of research and recommendations). Within each COM-B domain, we mapped facilitators and barriers to physical and psychological capability, physical and social opportunity, and how the interplay between these domains influences motivation. CONCLUSIONS: These findings can inform policy and guideline development and improve implementation of MgSO4 in clinical care. Such action is needed to ensure this life-saving treatment is widely available and appropriately used. TWEETABLE ABSTRACT: Global qualitative review identifies factors affecting underutilisation of MgSO4 for pre-eclampsia and eclampsia.
引用
- Eddy KE, Vogel JP, Zahroh RI, et al. Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis. BJOG. 2021. PMID: 34520111. doi:10.1111/1471-0528.16913
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。